University of New South Wales
Australia
His primary scientific interests are in Surgery, Carcinoma, Ovarian cancer, Internal medicine and Cancer. His Carcinoma research incorporates themes from Survival rate, Retrospective cohort study, Stage, Radical Vulvectomy and Survival analysis. His studies in Ovarian cancer integrate themes in fields like Endometriosis, Gynecology, Pathology, Cell adhesion molecule and General surgery.
As part of the same scientific family, Neville F. Hacker usually focuses on Gynecology, concentrating on Obstetrics and intersecting with Cervix and Ectopic pregnancy. While the research belongs to areas of Internal medicine, Neville F. Hacker spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Combination chemotherapy. His Cancer research includes themes of Cancer research, Methylation and DNA methylation.
His primary areas of study are Ovarian cancer, Internal medicine, Surgery, Oncology and Cancer. His work carried out in the field of Ovarian cancer brings together such families of science as Cancer research, Metastasis, Immunology and Pathology. The concepts of his Pathology study are interwoven with issues in Ovary and Adenocarcinoma.
In his research on the topic of Internal medicine, Immunotherapy is strongly related with Gastroenterology. His work on Disease expands to the thematically related Surgery. His research investigates the connection between Cancer and topics such as Gynecology that intersect with problems in Obstetrics, Hysterectomy, Endometrial cancer, Referral and Incidence.
Neville F. Hacker mostly deals with Ovarian cancer, Cancer, Internal medicine, Cancer research and Oncology. Neville F. Hacker has researched Ovarian cancer in several fields, including Cancer cell, Serous fluid, Antibody and Metastasis. The Cancer study combines topics in areas such as Gynecology, Disease, MEDLINE and Ascites.
His Internal medicine research is multidisciplinary, incorporating perspectives in Wnt signaling pathway and Drug resistance. The study incorporates disciplines such as Cell migration, DNA methylation, Ovarian carcinoma, Ovarian cancer cells and DNA repair in addition to Cancer research. His Oncology research incorporates elements of Chemotherapy, Regimen, Epithelial ovarian cancer, Stage and Survival analysis.
Neville F. Hacker spends much of his time researching Ovarian cancer, Cancer, Cancer research, Internal medicine and Gynecology. Neville F. Hacker has included themes like Wnt signaling pathway, Cancer cell, Serous fluid, Metastasis and Survival analysis in his Ovarian cancer study. His Cancer study also includes
His study in Cancer research is interdisciplinary in nature, drawing from both Ovarian carcinoma, SFRP4, DNA methylation and Prostate cancer. Neville F. Hacker usually deals with Internal medicine and limits it to topics linked to Oncology and Stage and Cell. His study looks at the relationship between Gynecology and topics such as Standardized rate, which overlap with Vulvar cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Zhen Zhang;Robert C. Bast;Yinhua Yu;Jinong Li.
Cancer Research (2004)
PRIMARY CYTOREDUCTIVE SURGERY FOR EPITHELIAL OVARIAN CANCER
N F Hacker;J S Berek;L D Lagasse;R K Nieberg.
Obstetrics & Gynecology (1983)
Practical gynecologic oncology
Jonathan S. Berek;Neville F. Hacker.
(1989)
Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial
Pierluigi Benedetti Panici;Angelo Maggioni;Neville Hacker;Fabio Landoni.
Journal of the National Cancer Institute (2005)
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva.
James M. Heaps;Yao S. Fu;Fredrick J. Montz;Neville F. Hacker.
Gynecologic Oncology (1990)
Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight.
I. Juraskova;P. Butow;R. Robertson;L. Sharpe.
Psycho-oncology (2003)
Survival of patients following secondary cytoreductive surgery in ovarian cancer.
Berek Js;Hacker Nf;Lagasse Ld;Nieberg Rk.
Obstetrics & Gynecology (1983)
Reproductive and other factors and risk of epithelial ovarian cancer: An australian case-control study
David Purdie;Adèle Green;Christopher Bain;Victor Siskind.
International Journal of Cancer (1995)
Distant metastases in epithelial ovarian carcinoma
Jacques Dauplat;Neville F. Hacker;Roberta K. Nieberg;Jonathan S. Berek.
Cancer (1987)
Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA
Jonathan S. Berek;Candace Howe;Leo D. Lagasse;Neville F. Hacker.
Gynecologic Oncology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Stanford University
University of New South Wales
Garvan Institute of Medical Research
The University of Texas MD Anderson Cancer Center
Garvan Institute of Medical Research
Macquarie University
University of Sydney
Russian Academy of Sciences
Harvard Medical School
University of Copenhagen
Shanghai Jiao Tong University
University of Southern California
National Central University
Hunan University
Norwegian University of Life Sciences
Charité - University Medicine Berlin
Seoul National University
University of Pennsylvania
Western Sydney University
University of North Carolina at Greensboro
University of California, Davis
TU Dresden
Mayo Clinic
Kyoto University
Cornell University
National Institutes of Health